VFS
UTHR icon

VSR Financial Services’s United Therapeutics UTHR Stock Holding History

VSR Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,195
Closed -$467K – 584
2016
Q1 		$467K Buy
4,195
+35
+0.8% +$4.43K 0.05% 335
2015
Q4 		$651K Hold
4,160
– – 0.07% 272
2015
Q3 		$546K Hold
4,160
– – 0.06% 293
2015
Q2 		$724K Buy
+4,160
New +$748K 0.08% 278

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

VSR Financial Services's UTHR Position: Q2 2016 in Review

VSR Financial Services sold out of United Therapeutics (UTHR) in Q2 2016, closing a stake of 4,195 shares — an estimated $467K sold.

VSR Financial Services first reported a position in UTHR in Q2 2015 and held it in 4 quarters. The position peaked at $724K in Q2 2015. 384 funds tracked by Wall St. Rank hold UTHR as of Q2 2016.

  • VSR Financial Services reported no remaining United Therapeutics position as of Q2 2016 after selling out during the quarter.
  • VSR Financial Services sold 4,195 United Therapeutics shares in Q2 2016, an estimated $467K.
  • VSR Financial Services first reported a position in United Therapeutics in Q2 2015 and held it in 4 quarters.
  • VSR Financial Services's United Therapeutics position peaked at $724K in Q2 2015.
  • 384 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.